IBM Turns 100: Marks Numerous Contributions to Healthcare

IBM HealthcareIBM is marking the 100-year anniversary of its founding on June 16, 1911. Few areas of health and medicine have gone untouched by the technology, research and innovation generated by IBM over the past century.

From the first continuous blood separator which led to treatment for leukemia patients, the first heart lung machine to keep patients alive during surgery, the excimer laser used in LASIK eye surgery, to technologies of the future that will one day allow nano-sized particles to enter the bloodstream and fight drug-resistant infections, IBM touches more points in healthcare than anyone else.

IBM has created hardware and applications specifically designed to improve care, improved diagnostics and treatment of disease, and advanced how medical knowledge is shared. This goes far beyond computers. New areas of Research including breakthroughs in gene sequencing and nanotechnology and even innovations in chip design are improving healthcare around the world.

  • In the 1950s, IBM built the first heart-lung machine to be used successfully on a person during surgery.
  • IBM and the National Cancer Institute collaborated in the 1960s to invent the first continuous blood cell separator, which was used for harvesting white cells (and, later, platelets) to treat leukemia patients.
  • Working with the World Health Organization, IBM precisely mapped outbreaks of smallpox in 1976, enabling WHO to allocate its limited personnel and resources to the most urgent locations. The system later became a global model for demographic tracking.
  • IBM invented the method for using excimer lasers that eventually became photorefractive (LASIK) eye surgery.
  • In the early 1990s IBM and the University of Washington built a prototype of the first medical imaging system.
  • IBM's World Community Grid, released in 2004, uses pervasive networking and crowdsourcing to apply supercomputer levels of processing power to urgent healthcare and societal needs such as fighting AIDs, cancer and dengue fever and malaria.
  • Using IBM's Blue Gene supercomputing simulations, researchers at IBM and the University of Edinburgh are currently collaborating on lab experiments to design drugs aimed at preventing the spread of the HIV virus. Until recently, doctors had to make an educated guess about what mix of drugs would work for patients. By simulating the effect of drug cocktails virtually, IBM is helping patients and breaking new barriers in personalized medicine.
  • IBM is currently working with Roche on a DNA Transistor, a high-tech and low-cost way of reading the human genome sequence. This technology may soon be used to create better patient profiles, tailor-made diagnoses and treatments informed by genetics-driving down the cost of healthcare while drastically improving quality of care and quality of life.

Using principles and technologies from computing, physics, material sciences and chemistry, IBM Research has a track record of successfully transferring technology to create new solutions for healthcare. The company spends more than $6B a year on R&D, much of it on healthcare, and IBM is one of the few technology companies with large teams of physicians and other clinicians on staff to ensure we are addressing healthcare's most pressing needs.

Related news articles:

About IBM
For more information about IBM, visit: http://www.ibm.com.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...